Metraipolis › archive › dc_4543da0d94cf

A Comparative Evaluation of the Effects of Saroglitazar and Pioglitazone on Hepatic and Metabolic Parameters in Type 2 Diabetes Mellitus With Metabolic… — Europe PMC PMID:41583325

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41583325
DOI
10.7759/cureus.100002
License (as archived)
solo-consultazione
Archived
2026-11-07T10:40:03.291Z
SHA-256 of the archived text
b3ae21718a18cd0ac1f88b1165fcb3a161ff6477e62f6c4d14513ff2d6ddfb8b
Stable URL of this page
https://metraipolis.com/documento/dc_4543da0d94cf

How to cite

A Comparative Evaluation of the Effects of Saroglitazar and Pioglitazone on Hepatic and Metabolic Parameters in Type 2 Diabetes Mellitus With Metabolic… — Europe PMC PMID:41583325 — Europe PMC (en), https://europepmc.org/article/MED/41583325 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4543da0d94cf (Metraipolis archive dc_4543da0d94cf, sha256 b3ae21718a18cd0ac1f88b1165fcb3a161ff6477e62f6c4d14513ff2d6ddfb8b)
BibTeX
@misc{dc4543da0d94cf,
  title = {A Comparative Evaluation of the Effects of Saroglitazar and Pioglitazone on Hepatic and Metabolic Parameters in Type 2 Diabetes Mellitus With Metabolic… — Europe PMC PMID:41583325},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41583325},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4543da0d94cf; sha256 b3ae21718a18cd0ac1f88b1165fcb3a161ff6477e62f6c4d14513ff2d6ddfb8b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41583325. Agents can read the archived copy with the MCP tool read_document.